Search Results 491-500 of 17407 for prednisone

  1. VG161 in the Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma - Mayo Clinic

    (> 10 mg daily prednisone equivalent) or other immunosuppressive medications within 14 days prior to dosing. Inhaled or topical steroids, and adrenal ...

  2. Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma - Mayo Clinic

    ... prednisone or methylprednisolone does not affect eligibility; Intrathecal cytarabine (the CNS status must be determined based on a sample obtained prior to ...

  3. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

    Hematopoietic cell transplantation (HCT) recipients newly requiring systemic glucocorticoid therapy (at ≥ 1mg/kg/day prednisone or equivalent) for chronic GVHD ...

  4. Amiodarone (oral route) - Mayo Clinic

    Amiodarone is used to treat life-threatening heart rhythm problems called ventricular arrhythmias. This medicine is used in patients who have already been ...

  5. Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) - Mayo Clinic

    ... prednisone or equivalent permitted - Adrenal replacement steroid doses including doses >10 mg daily prednisone is permitted - A brief (less than 3 weeks) ...

  6. Rifampin (oral route) - Mayo Clinic

    Prednisone; Raltegravir; Repaglinide; Rofecoxib; Sertraline; Triazolam; Trimetrexate; Valproic Acid; Zaleplon. Other Interactions. Certain medicines should not ...

  7. Levofloxacin (intravenous route) - Mayo Clinic

    The risk of having tendon problems may be increased if you are over 60 years of age, are using steroid medicines (eg, dexamethasone, prednisolone, prednisone ...

  8. To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active Chronic Inflammatory Demyelinating Polyneuropathy - Mayo Clinic

    Are receiving chronic oral corticosteroids monotherapy at a dose > 40 mg/day or < 20 mg/day prednisolone/prednisone or its equivalent at the Screening Visit.

  9. A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS - Mayo Clinic

    ... prednisone therapy at ≥ 1 mg/kg/day, a trial of calcineurin inhibitor for=> 3 months or a contraindication/intolerance to such therapy (diabetes ...

  10. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

    ... prednisone for 2 weeks if oral or 1 week if IV or ≥ 9 mg/day oral budesonide. Intolerance to CS therapy: History including, but not limited to, Cushing's ...